MannKind Reports 30-week Results From Phase 4 INHALE-3 Study …
WEB21 hours ago · (RTTNews) - MannKind (MNKD) reported top-level 30-week results from Phase 4 INHALE-3 study, in which additional patients living with type 1 diabetes achieved target A1c levels during the...
Mankind Pharma board approves up to Rs 10,000 crore
WEB19 hours ago · Mankind Pharma on Monday said it will raise up to Rs 10,000 crore via issuance of non-convertible debentures and commercial papers. The company said its board has approved to raise up to Rs 5,000...
Mankind Pharma shares in focus as company approves Rs 10,000 …
WEB5 hours ago · Mankind Pharma shares are expected to remain in Focus on Tuesday as the company announced that it would raise up to Rs 10,000 crore through issuance of non-convertible debentures and commercial papers.
MannKind Corporation (MNKD) Latest Stock News & Headlines
WEBGet the latest MannKind Corporation (MNKD) stock news and headlines to help you in your trading and investing decisions.
MNKD News Today | Why did MannKind stock go down today?
WEB5 days ago · Bank of New York Mellon Corp lifted its stake in MannKind Co. (NASDAQ:MNKD - Free Report) by 14.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 915,248 shares of the biopharmaceutical company's sto. September 14, 2024 | marketbeat.com.
MannKind Corporation (MNKD) Stock Price, News, Quote
WEBFind the latest MannKind Corporation (MNKD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Analysts Just Made A Meaningful Upgrade To Their MannKind …
WEBMar 3, 2024 · Celebrations may be in order for MannKind Corporation (NASDAQ:MNKD) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The consensus ...
MNKD Stock Price | MannKind Corp. Stock Quote (U.S.: Nasdaq)
WEB4 days ago · MNKD | Complete MannKind Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
MannKind rises as FDA advances rare lung disease therapy to …
WEBApr 29, 2024 · MannKind (NASDAQ: MNKD) shares rose 13% premarket on Monday after the U.S. drug regulator cleared its clofazimine inhalation suspension (MNKD 101) for a Phase 3 study to treat nontuberculous...
MannKind Corporation (MNKD) Stock Price, Quote, News & Analysis
WEB4 days ago · A high-level overview of MannKind Corporation (MNKD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.